An investigation of an endolichenic Beauveria sp.
led to the discovery of seven new cyclotetradepsipeptides, beauveamides
A–G (2–8), along with the
known beauverolide Ka (1). All incorporate a 3-hydroxy-4-methyldecanoic
acid (HMDA) moiety in their structures. Their configuration was determined
through Marfey’s, J-based configuration analysis,
and NMR computational methods, representing the first time that the
stereostructures of HMDA-moiety-containing cyclotetradepsipeptides
have been established. Compounds 1 and 2 exhibited protecting effects on HEI-OC1 cells at 10 μM, while 1, 4, and 5 could stimulate glucose
uptake in cultured rat L6 myoblasts at 50 μM. Compound 1 showed dose-dependent activity in both L6 myoblasts and
myotubes.